President Donald Trump said on Tuesday that the United States would initially place a "small tariff" on pharmaceutical ...

Heart murmurs occurring in nearly one in four adults, but recordings of stethoscope sounds have limited sensitivity in ...

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...

We will be totally self-sufficient for the supply of medicines to American patients.” AstraZeneca CEO Pascal Soriot on the ...

Today’s Forbes CFO newsletter focuses on Aradhana Sarin’s journey from treating patients to becoming what she calls a ...

Trump is pushing drug companies to lower their prices, but experts cast doubt on how effective this endeavor will prove.

The Department of Health and Human Services (HHS) is winding down its mRNA vaccine development activities under the ...

Out-licensing drugs to multinational corporations is a natural step for Chinese biotechs, but the recent rise in deals is ...

While a substantial portion of pipeline assets are externally sourced, many Big Pharmas are tapping into incubators and ...

President Trump on Tuesday threatened to impose tariffs of up to 250 percent on pharmaceutical imports, the highest rate he’s ...

For more information on SOPHiA GENETICS, visit SOPHiAGENETICS.COM, or connect on LinkedIn .

The Department of Health and Human Services has announced a plan to end mRNA vaccine work funded by the Biomedical Advanced ...